CATALYST PATHWAYS
LIVE

Serial Number

87935255

Owner

Catalyst Pharmaceuticals, Inc.

Attorney

Peter A. Chiabotti

First Use Date

Dec 2, 2018

Filing Date

May 24, 2018

Add to watchlist:

No watchlists yet
View on USPTO

CATALYST PATHWAYS Trademark

Serial Number: 87935255 • Registration: 6283545

CATALYST PATHWAYS is a trademark filed by Catalyst Pharmaceuticals, Inc. on May 24, 2018. The trademark is classified under Class 36 (Insurance & Financial), Class 44 (Medical Services), Class 45 (Legal & Security Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Catalyst Pharmaceuticals, Inc. (4 trademarks)

Coral Gables, FL 33134

Entity Type: 03

Trademark Details

Filing Date

May 24, 2018

Registration Date

March 2, 2021

First Use Anywhere

December 2, 2018

First Use in Commerce

January 25, 2019

Published for Opposition

November 5, 2019

Goods & Services

Providing health insurance information about health insurance benefits to patients and healthcare professionals; financial consultation to medical patients in obtaining reimbursement of health care costs and identification of health insurance alternatives

Assisting patients by coordinating with patients, pharmacies, payors, and physician offices in healthcare benefits' investigation, verification and pharmaceutical prescriptions and refills and locating support programs to aid in out of pocket healthcare costs, namely, third-party charitable foundations, company-sponsored charity care, and copay-assistance programs for commercially insured patients

Providing billing information and medical billing support services to patients and healthcare professionals; administering pharmacy reimbursement programs and services for business purposes; providing physician's offices with commercial information, input and guidance on navigating the prior approval process for pharmaceutical products

Medical patient support services, namely, providing information relating to the therapeutic properties of pharmaceuticals, providing information relating to healthcare, disease management, and pharmaceutical dosing and safety information to patients and healthcare professionals

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
May 29, 2026 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
May 29, 2026 C15A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
May 29, 2026 APRE
TEAS SECTION 8 & 15 RECEIVED
Mar 9, 2026 E815
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Mar 2, 2026 REM1
REGISTERED-PRINCIPAL REGISTER
Mar 2, 2021 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jan 27, 2021 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jan 26, 2021 CNPR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 6, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 6, 2021 CRFA
ASSIGNED TO LIE
Dec 29, 2020 ALIE
STATEMENT OF USE PROCESSING COMPLETE
Dec 28, 2020 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Dec 18, 2020 AITU
USE AMENDMENT FILED
Dec 7, 2020 IUAF
TEAS STATEMENT OF USE RECEIVED
Dec 7, 2020 EISU
ASSIGNED TO EXAMINER
Jul 23, 2020 DOCK
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 2, 2020 EXRA
SOU EXTENSION 1 GRANTED
Jun 30, 2020 EX1G
SOU EXTENSION 1 FILED
Jun 30, 2020 EXT1
SOU TEAS EXTENSION RECEIVED
Jun 30, 2020 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 31, 2019 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 5, 2019 NPUB
PUBLISHED FOR OPPOSITION
Nov 5, 2019 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 16, 2019 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 30, 2019 CNSA
EXAMINER'S AMENDMENT ENTERED
Sep 12, 2019 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sep 12, 2019 GNEN
EXAMINERS AMENDMENT E-MAILED
Sep 12, 2019 GNEA
EXAMINERS AMENDMENT -WRITTEN
Sep 12, 2019 CNEA
EXAMINER'S AMENDMENT ENTERED
Aug 27, 2019 XAEC
ASSIGNED TO LIE
Aug 26, 2019 ALIE
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 26, 2019 GNEN
EXAMINERS AMENDMENT E-MAILED
Aug 26, 2019 GNEA
EXAMINERS AMENDMENT -WRITTEN
Aug 26, 2019 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 3, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 2, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 2, 2019 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 3, 2019 GNRN
NON-FINAL ACTION E-MAILED
Feb 3, 2019 GNRT
NON-FINAL ACTION WRITTEN
Feb 3, 2019 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 29, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 28, 2018 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 28, 2018 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 20, 2018 GNRN
NON-FINAL ACTION E-MAILED
Sep 20, 2018 GNRT
NON-FINAL ACTION WRITTEN
Sep 20, 2018 CNRT
ASSIGNED TO EXAMINER
Sep 14, 2018 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 2, 2018 NWOS
NEW APPLICATION ENTERED
May 28, 2018 NWAP